Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 3
1951 2
1952 1
1956 1
1958 1
1964 2
1966 1
1968 1
1969 1
1975 2
1976 1
1977 1
1978 2
1979 3
1980 3
1981 6
1982 10
1983 5
1984 5
1985 5
1986 5
1987 6
1988 2
1989 4
1990 5
1991 3
1992 5
1993 3
1994 4
1995 9
1996 9
1997 6
1998 10
1999 8
2000 7
2001 8
2002 11
2003 7
2004 7
2005 9
2006 8
2007 5
2008 5
2009 8
2010 12
2011 17
2012 16
2013 16
2014 15
2015 12
2016 17
2017 20
2018 12
2019 24
2020 22
2021 30
2022 27
2023 20
2024 19
2025 20
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

489 results

Results by year

Filters applied: . Clear all
Page 1
Targeting a neoantigen derived from a common TP53 mutation.
Hsiue EH, Wright KM, Douglass J, Hwang MS, Mog BJ, Pearlman AH, Paul S, DiNapoli SR, Konig MF, Wang Q, Schaefer A, Miller MS, Skora AD, Azurmendi PA, Murphy MB, Liu Q, Watson E, Li Y, Pardoll DM, Bettegowda C, Papadopoulos N, Kinzler KW, Vogelstein B, Gabelli SB, Zhou S. Hsiue EH, et al. Among authors: miller ms. Science. 2021 Mar 5;371(6533):eabc8697. doi: 10.1126/science.abc8697. Epub 2021 Mar 1. Science. 2021. PMID: 33649166 Free PMC article.
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.
Mog BJ, Marcou N, DiNapoli SR, Pearlman AH, Nichakawade TD, Hwang MS, Douglass J, Hsiue EH, Glavaris S, Wright KM, Konig MF, Paul S, Wyhs N, Ge J, Miller MS, Azurmendi P, Watson E, Pardoll DM, Gabelli SB, Bettegowda C, Papadopoulos N, Kinzler KW, Vogelstein B, Zhou S. Mog BJ, et al. Among authors: miller ms. Sci Transl Med. 2024 Jul 10;16(755):eadg7123. doi: 10.1126/scitranslmed.adg7123. Epub 2024 Jul 10. Sci Transl Med. 2024. PMID: 38985855 Free PMC article.
Neonatal bradycardia.
Miller MS, Shannon KM, Wetzel GT. Miller MS, et al. Prog Pediatr Cardiol. 2000 May 1;11(1):19-24. doi: 10.1016/s1058-9813(00)00032-1. Prog Pediatr Cardiol. 2000. PMID: 10822186
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
Afkhami S, D'Agostino MR, Zhang A, Stacey HD, Marzok A, Kang A, Singh R, Bavananthasivam J, Ye G, Luo X, Wang F, Ang JC, Zganiacz A, Sankar U, Kazhdan N, Koenig JFE, Phelps A, Gameiro SF, Tang S, Jordana M, Wan Y, Mossman KL, Jeyanathan M, Gillgrass A, Medina MFC, Smaill F, Lichty BD, Miller MS, Xing Z. Afkhami S, et al. Among authors: miller ms. Cell. 2022 Mar 3;185(5):896-915.e19. doi: 10.1016/j.cell.2022.02.005. Epub 2022 Feb 9. Cell. 2022. PMID: 35180381 Free PMC article.
Immunological considerations for COVID-19 vaccine strategies.
Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Jeyanathan M, et al. Among authors: miller ms. Nat Rev Immunol. 2020 Oct;20(10):615-632. doi: 10.1038/s41577-020-00434-6. Epub 2020 Sep 4. Nat Rev Immunol. 2020. PMID: 32887954 Free PMC article. Review.
Early innate immune response and evolution of a SARS-CoV-2 furin cleavage site inactive variant in bat cells.
Baid K, Shrivastava S, Luc J, Richard D, Aguiar JA, Machado Y, Aicher SM, Siwak KC, LeBlanc EV, Khatooni Z, Lokugamage KG, Vu MN, Morgan A, Bhuinya A, Chiok KR, Nguyen HT, Stacey HD, Scruten E, Prysliak T, Yim W, McArthur AG, Miller MS, Wilson HL, Capellini T, Faure PA, Liu Q, Mubareka S, Menachery VD, Mossman K, Müller MA, Drosten C, Colpitts CC, Jouvenet N, Overall CM, Doxey AC, Banerjee A. Baid K, et al. Among authors: miller ms. Cell Rep. 2025 Jul 22;44(7):115929. doi: 10.1016/j.celrep.2025.115929. Epub 2025 Jul 1. Cell Rep. 2025. PMID: 40608518 Free article.
Computational design of potent and selective binders of BAK and BAX.
Berger S, Lee EF, Harris TJ, Tran S, Bera AK, Arguinchona L, Kang A, Sankaran B, Kasapgil S, Miller MS, Smyth S, Lutfi M, Uren RT, Kluck RM, Colman PM, Fairlie WD, Czabotar PE, Baker D, Birkinshaw RW. Berger S, et al. Among authors: miller ms. Sci Adv. 2025 Sep 5;11(36):eadt4170. doi: 10.1126/sciadv.adt4170. Epub 2025 Sep 5. Sci Adv. 2025. PMID: 40911686 Free PMC article.
Cancer Prevention/Interception Agent Development.
Miller MS, Ondrey FG. Miller MS, et al. Cancer Prev Res (Phila). 2025 Nov 3;18(11):659-662. doi: 10.1158/1940-6207.CAPR-25-0216. Cancer Prev Res (Phila). 2025. PMID: 41178361 Review.
489 results